The Center supports clients across the development and manufacturing of biologics, RNA therapeutics, vaccines, and cell and gene therapies.

The world’s first single-dose vaccine to prevent dengue fever has been approved for licensure in one of the largest countries ...

The first volunteer has received a dose in a first-in-human trial of Oxford's Lassa fever vaccine, a major milestone in ...

Dr. Vadim Jucaud's lab at the Terasaki Institute has introduced a new organ-on-a-chip platform that recapitulates ...

The World Health Organisation (WHO) has identified Lassa fever as a priority pathogen in urgent need of research and ...

To accurately gauge a vaccine’s risks, it is also crucial to compare its side effects with the effects of the illness it ...

A world-first single-dose vaccine against the dengue virus, manufactured and approved for use in Brazil, will especially ...

The commissioners’ concerns are in response to sweeping vaccine regulation changes earmarked by CBER head Vinay Prasad.

‘Chief Medical Officer’s Annual Report 2025: Infections’ was published at 15:00 UK time on Thursday the 4th of December 2025. Prof Andrew Morris: Andrew is the President of the Academy of Medical ...

RFK Jr’s vaccine advisory panel will be discussing the inclusion of adjuvants in childhood vaccinations this week. Here’s ...

A world-first single-dose vaccine against the dengue virus, manufactured and approved for use in Brazil, will especially ...

By 2025, more than 13 billion doses of the vaccine are estimated to have been administered globally, saving untold millions ...